Table 1.

Characteristics of Urothelial Carcinoma Patients (N=41).

Characteristics	Overall	Disease Status		P-value‡
		Refractory* n=29 (71%)	Response† n=12 (29%)
Age (years)	66.0 (49.0–83.0)	69.0 (47.5–82.5)	65.0 (51.0–87.0)	0.39§
Gender
Female	16 (39.0)	9 (31.0)	7 (58.3)
Male	25 (61.0)	20 (69.0)	5 (41.7)	0.16
Tumor Stage
pTa	12 (29.3)	8 (27.5)	4 (33.3)
pTis	15 (36.6)	10 (34.5)	5 (41.7)
pT1	13 (31.7)	10 (34.5)	3 (25.0)
T1	1 (2.4)	1 (3.5)	0 (0)	0.88
Tumor Grade
Non-invasive	28 (68.3)	18 (62.1)	10 (83.3)
Invasive	13 (31.7)	11 (37.9)	2 (16.7)	0.28
Tumor Architecture
Flat	22 (53.7)	16 (55.2)	6 (50.0)
Papillary	19 (46.3)	13 (44.8)	6 (50.0)	1.0
Prior history of BCG therapy||
No	22 (53.7)	11 (37.9)	11 (91.7)
Yes	19 (46.3)	18 (62.1)	1 (8.3)	0.002
Smoking
Never	13 (31.7)	10 (34.5)	3 (25.0)
Ever	28 (68.3)	19 (65.5)	9 (75.0)	0.72

^*Refractory Disease Status: Patients with No response to therapy.

^†Response Disease Status: Patients with no evidence of disease for at least 2 years after one cycle of BCG.

^‡Fishers exact test.

^§Wilcoxon rank sum test.

^||Prior history of BCG therapy: Bacillus Calmette-Guerin (BCG) treatment before admittance to Memorial Sloan Kettering Cancer Center (MSKCC).